Option chain shows key data for North American Cannabis's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for North American Cannabis.

North American Cannabis (OTC:USMJ) Stock, Option Chain

North American Cannabis Holdings Inc is engaged in building a hemp and cannabis growing capacity, a testing facility and a hemp and cannabis-related clothing business. The company is engaged in finding various possible applications for cannabis to serve consumers.

Cannabis

News

Markets

PAOG

PURA

USMJ

Puration, Inc. (OTCPK:PURA) and PAO Group, Inc. (OTCPK:PAOG) are working together on a new line of CBD Nutraceuticals under PURA’s Farmersville Hemp Brand Name for the women’s health market.

PURA And PAOG To Launch CBD Product Line For Women&#39;s Health Market In April

PJET

North American Cannabis Holdings, Inc. (OTCPK:USMJ) announced the company will officially launch a major expansion of its cannabis ecommerce business next week on Thursday, February 17, 2022. The launch will be centered on North American’s first marketing campaign for the EVERx CBD Sports Nutrition Beverage.

North American Cannabis Holdings To Expand Ecommerce Starting With EVERx CBD Sports Nutrition Beverage

North American Cannabis Holdings, Inc. (OTCPK: USMJ) announced that it’s poised to kickoff a major expansion of its cannabis ecommerce business.

North American Cannabis Holdings To Launch Marijuana Ecommerce Expansion Campaign

NORTH AMER CANNABIS HLDG by North American Cannabis Holdings, Inc.

North American Cannabis Holdings Inc

Analyst Ratings

Trading Ideas

On CNBC, Stephanie Link Announced Bought More Rockwell Automation

ABBV

CSCO

On CNBC, Jim Lebenthal Announced Bought More AbbVie; Bought More Cisco Systems

TD Cowen analyst Oliver Chen maintains BJ's Wholesale Club (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BJ#NYSE">BJ</a>) with a Buy and raises the price target from $95 to $110.

Price Target

TD Cowen Maintains Buy on BJ's Wholesale Club, Raises Price Target to $110

Morgan Stanley analyst David Arcaro maintains DTE Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DTE#NYSE">DTE</a>) with a Overweight and lowers the price target from $131 to $128.

Morgan Stanley Maintains Overweight on DTE Energy, Lowers Price Target to $128

Jefferies analyst Julien Dumoulin-Smith initiates coverage on UGI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UGI#NYSE">UGI</a>) with a Buy rating and announces Price Target of $28.

Initiation

Jefferies Initiates Coverage On UGI with Buy Rating, Announces Price Target of $28

Live On CNBC, Kevin Simpson Announces Sold Walmart

Live On CNBC, Stephanie Link Announces Bought More Gap, Inc.

TD Cowen analyst Doug Creutz maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Buy and raises the price target from $176 to $211.

TTWO

TD Cowen Maintains Buy on Take-Two Interactive, Raises Price Target to $211

Morgan Stanley analyst David Arcaro maintains Constellation Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) with a Overweight and lowers the price target from $323 to $322.

Morgan Stanley Maintains Overweight on Constellation Energy, Lowers Price Target to $322

Morgan Stanley analyst David Arcaro maintains Consolidated Edison (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ED#NYSE">ED</a>) with a Underweight and lowers the price target from $88 to $85.

Morgan Stanley Maintains Underweight on Consolidated Edison, Lowers Price Target to $85

TD Cowen analyst Andrew Sherman maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Buy and raises the price target from $70 to $82.

PCOR

TD Cowen Maintains Buy on Procore Technologies, Raises Price Target to $82

Jefferies analyst Brent Thill maintains Procore Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PCOR#NYSE">PCOR</a>) with a Hold and raises the price target from $70 to $80.

Jefferies Maintains Hold on Procore Technologies, Raises Price Target to $80

On Wednesday, the Department of Justice released its remedy requests aimed at curbing Google&#8217;s search engine dominance. Alphabet, Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google responded that the proposed remedies were "staggering." Analysts are sharing their <a href="https://www.benzinga.com/government/regulations/24/11/42119020/alphabet-bleeds-over-120-billion-in-market-value-eyes-worst-day-in-10-months-after-doj-demands-google-chrome-sale">reactions as well. </a>
<ul>
<li>BMO Capital Markets analyst Brian Pitz reiterated an Outperform rating on Alphabet and kept the price target at $217.</li>
<li>JPMorgan analyst Doug Anmuth maintains Alphabet with an Overweight rating and raised the price target to $212.</li>
<li>Goldman Sachs analyst Eric Sheridan maintained a Buy rating and kept the price target at $210.</li>
</ul>
Read More: <a href="https://www.benzinga.com/general/social-media/24/11/42119493/rumble-eyes-buying-bitcoin-could-it-be-the-next-microstrategy">Rumble CEO Considers Bitcoin Investment, Engages Michael Saylor As Shares Rally</a>
Pitz described the sweeping remedies proposed by the DOJ as a "kitchen sink moment.&#8221; Pitz noted that the DOJ's proposed remedies extend past Google's search distribution partnerships with Apple and Samsung and included the company's AI search-based investments. 
Anmuth echoed similar sentiments regarding the "very comprehensive" set of remedies proposed by the DOJ. He said parts of the remedies are "more punitive than expected" and listed those around consumer choice limitations and the syndication of search data and ads as examples. 
The DOJ's proposal should represent the worst-case scenario for Google, reminded Anmuth. He expects Google's proposed final remedies to be much more modest.&nbsp;
"Ultimately, we believe the judge's final decision next summer will be more balanced … and will likely have greater consideration around the potential negative impact to users," the JPMorgan analyst wrote.&nbsp;
Sheridan said the firm does not take a view on a potential outcome of the case. He noted, however, that leadership at the US DOJ will change in January with the incoming Trump administration which adds an additional variable to the potential outcomes of the trial. 
The analyst also pointed to recent comments from President-elect Donald Trump expressing skepticism on a potential break-up of Google.&nbsp;
"If you do that, are you going to destroy the company? What you can do without breaking it up is make sure it&#8217;s more fair,&#8221; Trump said in October, per Reuters.&nbsp;
Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Alphabet shares are down 1.55% at $166.62 at the time of publication Friday. 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/etfs/24/11/42044642/trump-appears-frustrated-as-elon-musk-chimes-in-on-treasury-secretary-adds-more-names-to-a-list-of-potential-picks">Trump Appears &#8216;Frustrated&#8217; As Elon Musk Chimes In On Treasury Secretary, Adds More Names To Short List&nbsp;</a></li>
</ul>
Image:&nbsp;Simon from Pixabay

Analyst Color

Government

Large Cap

Regulations

Reiteration

Legal

Movers

Tech

GOOG

GOOGL

'Staggering' Google Breakup Proposal From DOJ A 'Kitchen Sink Moment': Alphabet Analyst

Morgan Stanley analyst David Arcaro maintains CenterPoint Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNP#NYSE">CNP</a>) with a Equal-Weight and lowers the price target from $32 to $31.

Morgan Stanley Maintains Equal-Weight on CenterPoint Energy, Lowers Price Target to $31

"The signs are all pointing in the right direction. Let's just hope the speed picks up," says Josh Schiller, a partner at Boies Schiller Flexner, speaking about the progression of a Massachusetts-based lawsuit that could reshape the cannabis industry. The case challenges the federal government's enforcement of the Controlled Substances Act (CSA) against state-legal cannabis businesses, arguing that the federal approach violates constitutional principles.
At the center of the lawsuit is Justice Clarence Thomas' critique of federal cannabis policy. In 2021, Thomas called the federal government's stance "half in, half out," highlighting its contradictory approach to state-legal cannabis markets. Schiller's team argues that these contradictions undermine the rationale of the Supreme Court's 2005 decision in Gonzales v. Raich, which upheld federal authority under the Commerce Clause.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Josh Schiller Breaks Down Landmark Cannabis Lawsuit &amp; Federal Reform Implications &#x7C; Cultivated Live" width="500" height="281" src="https://www.youtube.com/embed/E6Ws42CkS5k?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
<h3 class="wp-block-heading">A New Era Of Legal Challenges</h3>
Filed in Massachusetts, the case seeks to address what Schiller describes as a fundamental shift in federal cannabis policy. In Raich, the federal government successfully argued that a consistent national prohibition was necessary to combat the illicit market. However, Schiller points to subsequent federal actions, such as congressional riders protecting state medical cannabis programs, as evidence that the government has abandoned its eradication strategy.
"Congress has taken steps to move away from the eradication policy," Schiller explains during the interview. He cites examples like the federal allowance of recreational cannabis sales in Washington, D.C., to show that federal priorities have evolved.
The lawsuit also addresses the practical challenges faced by cannabis businesses operating under the shadow of federal prohibition. "The financial consequences imposed by the federal government's continued overhang of illegality has consequences," Schiller says. He highlights issues such as excessive taxation under IRS Code 280E, limited access to banking and loans, and the reliance on cash-based operations due to federal banking restrictions.
<h3 class="wp-block-heading">Stakes For The Industry</h3>
If successful, the lawsuit could remove significant barriers for cannabis businesses, including the tax penalties imposed by 280E. "Everyone in this industry knows the taxation is discriminatory," Schiller notes, referring to how cannabis businesses are taxed on revenue rather than profit.
The case could also open the door to retroactive tax refunds, potentially worth billions, and pave the way for broader financial reforms. Schiller acknowledges that these changes could have transformative effects on the industry, leveling the playing field for businesses operating within state-legal frameworks.
<h3 class="wp-block-heading">What's Next?</h3>
Oral arguments in the U.S. Court of Appeals for the First Circuit are scheduled for December 5, 2024. Schiller explains that the court could either uphold the government's motion to dismiss or allow the case to proceed. If the plaintiffs are unsuccessful, the next step would be petitioning the Supreme Court to hear the case, although Schiller acknowledges that the Court takes on a limited number of cases.
"They're very selective," Schiller says of the Supreme Court. "They hear a very small single-digit percentage of the cases that they take on." However, Schiller believes the case could have appeal for some justices, particularly those like Justice Thomas, who have previously critiqued federal cannabis policy. &#8220;We also believe that Justice Gorsuch, who's a well-known author of federalist principles, would be interested in a case like this,&#8221; he adds.
Schiller emphasizes that a favorable ruling could fundamentally alter how the federal government interacts with state-regulated cannabis markets, potentially setting a precedent for other industries navigating federal-state conflicts.
<h3 class="wp-block-heading">A Pivotal Moment For Federalism</h3>
As the case moves forward, its implications extend beyond cannabis, touching on larger questions of federalism and constitutional authority. Schiller stresses the need for the courts to reassess how federal policies align with state-legal frameworks.
The plaintiffs argue that the federal government's continued criminalization of cannabis businesses operating lawfully under state laws creates unnecessary and discriminatory burdens, from excessive taxation to restricted access to financial services.
Schiller's team views the lawsuit as a step toward bridging the gap between federal actions and the progress made by states in regulating cannabis markets. The outcome could shape the future of cannabis policy in America, offering much-needed clarity for businesses and regulators alike.

Politics

VRNOF

Challenging Cannabis Prohibition: Lawyer Behind Same-Sex Marriage Takes On Federal Policy, Citing Justice Thomas' Critique

TD Cowen analyst John Kernan maintains TJX Companies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TJX#NYSE">TJX</a>) with a Buy and raises the price target from $130 to $132.

TD Cowen Maintains Buy on TJX Companies, Raises Price Target to $132

Morgan Stanley analyst Stephen Byrd maintains CMS Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMS#NYSE">CMS</a>) with a Equal-Weight and lowers the price target from $69 to $67.

Morgan Stanley Maintains Equal-Weight on CMS Energy, Lowers Price Target to $67

Jefferies analyst Brent Thill maintains Elastic (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ESTC#NYSE">ESTC</a>) with a Buy and raises the price target from $110 to $135.

ESTC

Jefferies Maintains Buy on Elastic, Raises Price Target to $135

Contracts

General Dynamics' Gulfstream Aerospace Secures $991M Contract to Provide Logistics Support for U.S. Military Aircraft Fleets Over Seven Years

China Renaissance analyst Yiming Wang upgrades XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) from Hold to Buy and announces $16.7 price target.

Comments

North American Cannabis

North American Cannabis (USMJ) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga